HEADER TRANSFERASE 17-JUN-21 7F40 TITLE LYSOPHOSPHOLIPID ACYLTRANSFERASE LPCAT3 IN A COMPLEX WITH TITLE 2 ARACHIDONOYL-COA COMPND MOL_ID: 1; COMPND 2 MOLECULE: LPCAT3; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: LPCAT3; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: EXPI293F; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCDNA3.4 KEYWDS LYSOPHOSPHOLIPID ACYLTRANSFERASE, LPCAT3, MEMBRANE-BOUND O- KEYWDS 2 ACYLTRANSFERASE, CRYO-EM, TRANSFERASE EXPDTA ELECTRON MICROSCOPY AUTHOR Q.ZHANG,D.YAO,B.RAO,S.LI,L.JIAN,Y.CHEN,K.HU,Y.XIA,Y.SHEN,Y.CAO REVDAT 3 15-DEC-21 7F40 1 COMPND HETNAM REVDAT 2 08-DEC-21 7F40 1 JRNL REVDAT 1 01-DEC-21 7F40 0 JRNL AUTH Q.ZHANG,D.YAO,B.RAO,L.JIAN,Y.CHEN,K.HU,Y.XIA,S.LI,Y.SHEN, JRNL AUTH 2 A.QIN,J.ZHAO,L.ZHOU,M.LEI,X.C.JIANG,Y.CAO JRNL TITL THE STRUCTURAL BASIS FOR THE PHOSPHOLIPID REMODELING BY JRNL TITL 2 LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 3. JRNL REF NAT COMMUN V. 12 6869 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 34824256 JRNL DOI 10.1038/S41467-021-27244-1 REMARK 2 REMARK 2 RESOLUTION. 3.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.490 REMARK 3 NUMBER OF PARTICLES : 292613 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7F40 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1300022813. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : LYSOPHOSPHOLIPID REMARK 245 ACYLTRANSFERASE 5 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : SPOT SCAN REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 ALA A 3 REMARK 465 GLU A 4 REMARK 465 ARG A 5 REMARK 465 ASP A 6 REMARK 465 GLU A 7 REMARK 465 SER A 8 REMARK 465 GLY A 9 REMARK 465 ALA A 10 REMARK 465 GLY A 11 REMARK 465 ALA A 12 REMARK 465 ALA A 13 REMARK 465 VAL A 14 REMARK 465 LEU A 15 REMARK 465 VAL A 16 REMARK 465 PRO A 17 REMARK 465 LEU A 18 REMARK 465 LEU A 19 REMARK 465 GLY A 20 REMARK 465 PHE A 21 REMARK 465 GLY A 22 REMARK 465 SER A 23 REMARK 465 ASN A 24 REMARK 465 ARG A 25 REMARK 465 PRO A 26 REMARK 465 ALA A 27 REMARK 465 GLY A 28 REMARK 465 PRO A 29 REMARK 465 ALA A 30 REMARK 465 GLU A 31 REMARK 465 LYS A 32 REMARK 465 MET A 33 REMARK 465 ALA A 34 REMARK 465 VAL A 35 REMARK 465 ALA A 36 REMARK 465 GLY A 37 REMARK 465 SER A 38 REMARK 465 GLY A 39 REMARK 465 TRP A 40 REMARK 465 SER A 41 REMARK 465 VAL A 491 REMARK 465 PRO A 492 REMARK 465 ARG A 493 REMARK 465 LYS A 494 REMARK 465 GLU A 495 REMARK 465 LYS A 496 REMARK 465 LEU A 497 REMARK 465 LYS A 498 REMARK 465 LYS A 499 REMARK 465 ALA A 500 REMARK 465 GLU A 501 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 ALA B 3 REMARK 465 GLU B 4 REMARK 465 ARG B 5 REMARK 465 ASP B 6 REMARK 465 GLU B 7 REMARK 465 SER B 8 REMARK 465 GLY B 9 REMARK 465 ALA B 10 REMARK 465 GLY B 11 REMARK 465 ALA B 12 REMARK 465 ALA B 13 REMARK 465 VAL B 14 REMARK 465 LEU B 15 REMARK 465 VAL B 16 REMARK 465 PRO B 17 REMARK 465 LEU B 18 REMARK 465 LEU B 19 REMARK 465 GLY B 20 REMARK 465 PHE B 21 REMARK 465 GLY B 22 REMARK 465 SER B 23 REMARK 465 ASN B 24 REMARK 465 ARG B 25 REMARK 465 PRO B 26 REMARK 465 ALA B 27 REMARK 465 GLY B 28 REMARK 465 PRO B 29 REMARK 465 ALA B 30 REMARK 465 GLU B 31 REMARK 465 LYS B 32 REMARK 465 MET B 33 REMARK 465 ALA B 34 REMARK 465 VAL B 35 REMARK 465 ALA B 36 REMARK 465 GLY B 37 REMARK 465 SER B 38 REMARK 465 GLY B 39 REMARK 465 TRP B 40 REMARK 465 SER B 41 REMARK 465 VAL B 491 REMARK 465 PRO B 492 REMARK 465 ARG B 493 REMARK 465 LYS B 494 REMARK 465 GLU B 495 REMARK 465 LYS B 496 REMARK 465 LEU B 497 REMARK 465 LYS B 498 REMARK 465 LYS B 499 REMARK 465 ALA B 500 REMARK 465 GLU B 501 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 49 49.32 -92.56 REMARK 500 HIS A 150 -71.72 -99.52 REMARK 500 TYR A 151 -52.09 -129.55 REMARK 500 THR A 184 76.59 52.90 REMARK 500 PRO A 185 -7.99 -51.69 REMARK 500 SER A 218 -166.88 -79.05 REMARK 500 VAL A 233 44.49 -143.56 REMARK 500 SER A 240 8.72 58.36 REMARK 500 VAL A 363 -57.08 -126.55 REMARK 500 ASN A 372 117.43 -161.20 REMARK 500 LEU A 390 -70.34 -84.12 REMARK 500 HIS A 391 -66.83 -122.57 REMARK 500 SER A 392 -24.19 -141.61 REMARK 500 TYR A 435 -163.84 -79.29 REMARK 500 THR A 440 7.97 57.31 REMARK 500 LEU B 49 49.34 -92.57 REMARK 500 HIS B 150 -71.72 -99.49 REMARK 500 TYR B 151 -52.11 -129.52 REMARK 500 THR B 184 76.61 52.85 REMARK 500 PRO B 185 -7.96 -51.76 REMARK 500 SER B 218 -166.86 -79.00 REMARK 500 VAL B 233 44.53 -143.60 REMARK 500 SER B 240 8.77 58.35 REMARK 500 VAL B 363 -57.06 -126.56 REMARK 500 ASN B 372 117.42 -161.21 REMARK 500 LEU B 390 -70.36 -84.12 REMARK 500 HIS B 391 -66.90 -122.58 REMARK 500 SER B 392 -24.24 -141.56 REMARK 500 TYR B 435 -163.85 -79.25 REMARK 500 THR B 440 8.03 57.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-31443 RELATED DB: EMDB REMARK 900 THE STRUCTURAL BASIS FOR THE PHOSPHOLIPID REMODELING BY REMARK 900 LYSOPHOSPHOLIPID ACYLTRANSFERASE LPCAT3 DBREF1 7F40 A 1 501 UNP A0A1L1RNG8_CHICK DBREF2 7F40 A A0A1L1RNG8 1 501 DBREF1 7F40 B 1 501 UNP A0A1L1RNG8_CHICK DBREF2 7F40 B A0A1L1RNG8 1 501 SEQRES 1 A 501 MET GLY ALA GLU ARG ASP GLU SER GLY ALA GLY ALA ALA SEQRES 2 A 501 VAL LEU VAL PRO LEU LEU GLY PHE GLY SER ASN ARG PRO SEQRES 3 A 501 ALA GLY PRO ALA GLU LYS MET ALA VAL ALA GLY SER GLY SEQRES 4 A 501 TRP SER LEU ALA ARG VAL ALA GLU ALA LEU GLY SER SER SEQRES 5 A 501 GLU GLN ALA LEU ARG LEU ILE VAL SER ILE LEU MET GLY SEQRES 6 A 501 TYR PRO PHE ALA LEU PHE GLN ARG TYR PHE LEU PHE GLN SEQRES 7 A 501 LYS GLU THR TYR LEU ILE HIS LEU TYR ASN VAL PHE THR SEQRES 8 A 501 GLY LEU SER ILE ALA TYR PHE ASN PHE GLY MET GLN PHE SEQRES 9 A 501 PHE HIS SER LEU LEU CYS VAL LEU ILE GLN PHE LEU ILE SEQRES 10 A 501 LEU ARG LEU MET GLY ARG THR VAL THR ALA VAL PHE THR SEQRES 11 A 501 THR PHE VAL PHE GLN MET THR TYR LEU MET ALA GLY TYR SEQRES 12 A 501 TYR PHE THR ALA THR GLU HIS TYR ASP ILE LYS TRP THR SEQRES 13 A 501 MET PRO HIS CYS VAL LEU THR LEU LYS LEU ILE GLY LEU SEQRES 14 A 501 ALA ILE ASP TYR TYR ASP GLY GLY LYS ASP PRO GLU LEU SEQRES 15 A 501 LEU THR PRO GLU GLN ARG ARG PHE ALA VAL ARG GLY VAL SEQRES 16 A 501 PRO THR LEU LEU GLU VAL SER GLY PHE SER TYR PHE TYR SEQRES 17 A 501 GLY ALA PHE MET VAL GLY PRO GLN PHE SER MET THR ASP SEQRES 18 A 501 TYR GLN LYS LEU ALA LYS GLY GLU MET THR ASP VAL PRO SEQRES 19 A 501 GLY GLN ARG PRO ASN SER PHE VAL PRO ALA LEU LYS ARG SEQRES 20 A 501 LEU SER LEU GLY LEU LEU PHE LEU VAL THR TYR THR LEU SEQRES 21 A 501 SER SER PRO TYR ILE SER GLU GLU TYR LEU ILE SER ASP SEQRES 22 A 501 ASP TYR MET GLU LYS PRO PHE TRP PHE ARG CYS GLY TYR SEQRES 23 A 501 ILE LEU VAL TRP GLY LYS ILE ILE LEU TYR LYS TYR VAL SEQRES 24 A 501 THR CYS TRP LEU VAL THR GLU GLY VAL CYS ILE LEU VAL SEQRES 25 A 501 GLY LEU GLY TYR ASN GLY ASN ASP GLN ASN GLY LYS PRO SEQRES 26 A 501 VAL TRP ASP ALA CYS ALA ASN MET LYS VAL TRP LEU TYR SEQRES 27 A 501 GLU THR THR PRO LEU PHE THR GLY THR ILE ALA SER PHE SEQRES 28 A 501 ASN ILE ASN THR ASN ALA TRP VAL ALA ARG TYR VAL PHE SEQRES 29 A 501 LYS ARG LEU LYS PHE LEU GLY ASN LYS LEU LEU SER GLN SEQRES 30 A 501 ALA LEU ALA LEU PHE PHE LEU ALA ILE TRP HIS GLY LEU SEQRES 31 A 501 HIS SER GLY TYR LEU VAL CYS PHE GLN MET GLU LEU LEU SEQRES 32 A 501 ILE VAL ILE VAL GLU ARG GLN VAL ILE ASN LEU VAL ARG SEQRES 33 A 501 ASP SER PRO THR LEU SER THR LEU ALA SER ILE THR ALA SEQRES 34 A 501 LEU GLN PRO ILE PHE TYR VAL LEU GLN GLN THR ASN HIS SEQRES 35 A 501 TRP MET PHE MET GLY TYR SER LEU VAL PRO PHE CYS LEU SEQRES 36 A 501 PHE THR TRP ASP LYS TRP MET LYS VAL TYR LYS SER ILE SEQRES 37 A 501 TYR PHE LEU GLY HIS VAL LEU PHE PHE THR LEU LEU LEU SEQRES 38 A 501 VAL LEU PRO TYR ILE ARG LYS LEU LEU VAL PRO ARG LYS SEQRES 39 A 501 GLU LYS LEU LYS LYS ALA GLU SEQRES 1 B 501 MET GLY ALA GLU ARG ASP GLU SER GLY ALA GLY ALA ALA SEQRES 2 B 501 VAL LEU VAL PRO LEU LEU GLY PHE GLY SER ASN ARG PRO SEQRES 3 B 501 ALA GLY PRO ALA GLU LYS MET ALA VAL ALA GLY SER GLY SEQRES 4 B 501 TRP SER LEU ALA ARG VAL ALA GLU ALA LEU GLY SER SER SEQRES 5 B 501 GLU GLN ALA LEU ARG LEU ILE VAL SER ILE LEU MET GLY SEQRES 6 B 501 TYR PRO PHE ALA LEU PHE GLN ARG TYR PHE LEU PHE GLN SEQRES 7 B 501 LYS GLU THR TYR LEU ILE HIS LEU TYR ASN VAL PHE THR SEQRES 8 B 501 GLY LEU SER ILE ALA TYR PHE ASN PHE GLY MET GLN PHE SEQRES 9 B 501 PHE HIS SER LEU LEU CYS VAL LEU ILE GLN PHE LEU ILE SEQRES 10 B 501 LEU ARG LEU MET GLY ARG THR VAL THR ALA VAL PHE THR SEQRES 11 B 501 THR PHE VAL PHE GLN MET THR TYR LEU MET ALA GLY TYR SEQRES 12 B 501 TYR PHE THR ALA THR GLU HIS TYR ASP ILE LYS TRP THR SEQRES 13 B 501 MET PRO HIS CYS VAL LEU THR LEU LYS LEU ILE GLY LEU SEQRES 14 B 501 ALA ILE ASP TYR TYR ASP GLY GLY LYS ASP PRO GLU LEU SEQRES 15 B 501 LEU THR PRO GLU GLN ARG ARG PHE ALA VAL ARG GLY VAL SEQRES 16 B 501 PRO THR LEU LEU GLU VAL SER GLY PHE SER TYR PHE TYR SEQRES 17 B 501 GLY ALA PHE MET VAL GLY PRO GLN PHE SER MET THR ASP SEQRES 18 B 501 TYR GLN LYS LEU ALA LYS GLY GLU MET THR ASP VAL PRO SEQRES 19 B 501 GLY GLN ARG PRO ASN SER PHE VAL PRO ALA LEU LYS ARG SEQRES 20 B 501 LEU SER LEU GLY LEU LEU PHE LEU VAL THR TYR THR LEU SEQRES 21 B 501 SER SER PRO TYR ILE SER GLU GLU TYR LEU ILE SER ASP SEQRES 22 B 501 ASP TYR MET GLU LYS PRO PHE TRP PHE ARG CYS GLY TYR SEQRES 23 B 501 ILE LEU VAL TRP GLY LYS ILE ILE LEU TYR LYS TYR VAL SEQRES 24 B 501 THR CYS TRP LEU VAL THR GLU GLY VAL CYS ILE LEU VAL SEQRES 25 B 501 GLY LEU GLY TYR ASN GLY ASN ASP GLN ASN GLY LYS PRO SEQRES 26 B 501 VAL TRP ASP ALA CYS ALA ASN MET LYS VAL TRP LEU TYR SEQRES 27 B 501 GLU THR THR PRO LEU PHE THR GLY THR ILE ALA SER PHE SEQRES 28 B 501 ASN ILE ASN THR ASN ALA TRP VAL ALA ARG TYR VAL PHE SEQRES 29 B 501 LYS ARG LEU LYS PHE LEU GLY ASN LYS LEU LEU SER GLN SEQRES 30 B 501 ALA LEU ALA LEU PHE PHE LEU ALA ILE TRP HIS GLY LEU SEQRES 31 B 501 HIS SER GLY TYR LEU VAL CYS PHE GLN MET GLU LEU LEU SEQRES 32 B 501 ILE VAL ILE VAL GLU ARG GLN VAL ILE ASN LEU VAL ARG SEQRES 33 B 501 ASP SER PRO THR LEU SER THR LEU ALA SER ILE THR ALA SEQRES 34 B 501 LEU GLN PRO ILE PHE TYR VAL LEU GLN GLN THR ASN HIS SEQRES 35 B 501 TRP MET PHE MET GLY TYR SER LEU VAL PRO PHE CYS LEU SEQRES 36 B 501 PHE THR TRP ASP LYS TRP MET LYS VAL TYR LYS SER ILE SEQRES 37 B 501 TYR PHE LEU GLY HIS VAL LEU PHE PHE THR LEU LEU LEU SEQRES 38 B 501 VAL LEU PRO TYR ILE ARG LYS LEU LEU VAL PRO ARG LYS SEQRES 39 B 501 GLU LYS LEU LYS LYS ALA GLU HET 3IX A 601 69 HET PCW A 602 54 HET 3IX B 601 69 HET PCW B 602 54 HETNAM 3IX S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-AMINOPURIN-9- HETNAM 2 3IX YL)-4-OXIDANYL-3-PHOSPHONOOXY-OXOLAN-2-YL]METHOXY- HETNAM 3 3IX OXIDANYL-PHOSPHORYL]OXY-OXIDANYL-PHOSPHORYL]OXY-3,3- HETNAM 4 3IX DIMETHYL-2-OXIDANYL- HETNAM 5 3IX BUTANOYL]AMINO]PROPANOYLAMINO]ETHYL] (5Z,8Z,11Z,14Z)- HETNAM 6 3IX ICOSA-5,8,11,14-TETRAENETHIOATE HETNAM PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE HETSYN 3IX ARACHIDONYL-COA HETSYN PCW (Z,Z)-4-HYDROXY-N,N,N-TRIMETHYL-10-OXO-7-[(1-OXO-9- HETSYN 2 PCW OCTADECENYL)OXY]-3,5,9-TRIOXA-4-PHOSPHAHEPTACOS-18-EN- HETSYN 3 PCW 1-AMINIUM-4-OXIDE FORMUL 3 3IX 2(C41 H66 N7 O17 P3 S) FORMUL 4 PCW 2(C44 H85 N O8 P 1+) HELIX 1 AA1 LEU A 42 GLU A 47 1 6 HELIX 2 AA2 SER A 52 MET A 64 1 13 HELIX 3 AA3 MET A 64 PHE A 75 1 12 HELIX 4 AA4 GLU A 80 PHE A 100 1 21 HELIX 5 AA5 GLN A 103 LEU A 120 1 18 HELIX 6 AA6 THR A 124 ALA A 147 1 24 HELIX 7 AA7 TRP A 155 GLY A 177 1 23 HELIX 8 AA8 LEU A 199 TYR A 206 1 8 HELIX 9 AA9 MET A 219 LYS A 227 1 9 HELIX 10 AB1 VAL A 242 SER A 262 1 21 HELIX 11 AB2 GLU A 267 ILE A 271 5 5 HELIX 12 AB3 PHE A 280 TRP A 290 1 11 HELIX 13 AB4 ILE A 293 GLY A 313 1 21 HELIX 14 AB5 TRP A 336 THR A 340 5 5 HELIX 15 AB6 PHE A 344 ALA A 349 1 6 HELIX 16 AB7 ASN A 352 VAL A 363 1 12 HELIX 17 AB8 ASN A 372 HIS A 388 1 17 HELIX 18 AB9 SER A 392 VAL A 415 1 24 HELIX 19 AC1 THR A 420 SER A 426 1 7 HELIX 20 AC2 ASN A 441 LEU A 455 1 15 HELIX 21 AC3 THR A 457 SER A 467 1 11 HELIX 22 AC4 PHE A 470 LEU A 490 1 21 HELIX 23 AC5 ALA B 43 GLU B 47 1 5 HELIX 24 AC6 SER B 52 MET B 64 1 13 HELIX 25 AC7 MET B 64 PHE B 75 1 12 HELIX 26 AC8 GLU B 80 PHE B 100 1 21 HELIX 27 AC9 GLN B 103 LEU B 120 1 18 HELIX 28 AD1 THR B 124 ALA B 147 1 24 HELIX 29 AD2 TRP B 155 GLY B 177 1 23 HELIX 30 AD3 LEU B 199 TYR B 206 1 8 HELIX 31 AD4 MET B 219 LYS B 227 1 9 HELIX 32 AD5 VAL B 242 SER B 262 1 21 HELIX 33 AD6 GLU B 267 ILE B 271 5 5 HELIX 34 AD7 PHE B 280 TRP B 290 1 11 HELIX 35 AD8 ILE B 293 GLY B 313 1 21 HELIX 36 AD9 TRP B 336 THR B 340 5 5 HELIX 37 AE1 LEU B 343 THR B 347 5 5 HELIX 38 AE2 ASN B 352 VAL B 363 1 12 HELIX 39 AE3 ASN B 372 HIS B 388 1 17 HELIX 40 AE4 SER B 392 VAL B 415 1 24 HELIX 41 AE5 THR B 420 SER B 426 1 7 HELIX 42 AE6 ASN B 441 LEU B 455 1 15 HELIX 43 AE7 THR B 457 SER B 467 1 11 HELIX 44 AE8 PHE B 470 LEU B 490 1 21 CISPEP 1 PRO A 238 ASN A 239 0 -5.17 CISPEP 2 PRO B 238 ASN B 239 0 -5.14 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000